Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.
Xu N, Fang W, Mu L, Tang Y, Gao L, Ren S, Cao D, Zhou L, Zhang A, Liu D, Zhou C, Wong KK, Yu L, Zhang L, Chen L.
Xu N, et al. Among authors: zhang l, zhang a.
Oncotarget. 2016 Jan 26;7(4):3884-96. doi: 10.18632/oncotarget.6461.
Oncotarget. 2016.
PMID: 26646697
Free PMC article.